Published in Biol Psychol on July 13, 2007
Emotion Regulation and the Anxiety Disorders: An Integrative Review. J Psychopathol Behav Assess (2010) 1.37
The effect of induced anxiety on cognition: threat of shock enhances aversive processing in healthy individuals. Cogn Affect Behav Neurosci (2011) 1.30
Does intolerance of uncertainty predict anticipatory startle responses to uncertain threat? Int J Psychophysiol (2011) 1.05
Sleep promotes consolidation and generalization of extinction learning in simulated exposure therapy for spider fear. J Psychiatr Res (2012) 0.99
Test-retest reliability of voluntary emotion regulation. Psychophysiology (2009) 0.97
Major depression is not associated with blunting of aversive responses; evidence for enhanced anxious anticipation. PLoS One (2013) 0.94
Mood symptoms and emotional responsiveness to threat in school-aged children. J Clin Child Adolesc Psychol (2011) 0.83
Effect of anxiety on behavioural pattern separation in humans. Cogn Emot (2015) 0.81
Depressed mood enhances anxiety to unpredictable threat. Psychol Med (2011) 0.81
Additive effects of threat-of-shock and picture valence on startle reflex modulation. PLoS One (2013) 0.81
Psychometric properties of startle and corrugator response in NPU, affective picture viewing, and resting state tasks. Psychophysiology (2016) 0.80
L-type Ca(2+) channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes. J Physiol (2016) 0.80
Negative affect impairs associative memory but not item memory. Learn Mem (2013) 0.77
Mental fatigue impairs emotion regulation. Emotion (2015) 0.75
Voluntary emotion regulation in anorexia nervosa: A preliminary emotion-modulated startle investigation. J Psychiatr Res (2016) 0.75
Anxiety and Depression Symptom Dimensions Demonstrate Unique Relationships with the Startle Reflex in Anticipation of Unpredictable Threat in 8 to 14 Year-Old Girls. J Abnorm Child Psychol (2016) 0.75
Defensive motivation and attention in anticipation of different types of predictable and unpredictable threat: A startle and event-related potential investigation. Psychophysiology (2017) 0.75
Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci (2002) 9.33
For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage (2004) 8.72
Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev (2001) 7.13
Emotion and motivation I: defensive and appetitive reactions in picture processing. Emotion (2001) 6.05
Habituation: a dual-process theory. Psychol Rev (1970) 3.95
A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol (2003) 2.91
Neural organization of the defensive behavior system responsible for fear. Psychon Bull Rev (1994) 2.79
A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci (1982) 2.73
Suppression and enhancement of emotional responses to unpleasant pictures. Psychophysiology (2000) 2.73
Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res (1993) 2.43
Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol (1999) 2.34
The startle probe response: a new measure of emotion? J Abnorm Psychol (1988) 2.24
Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology (1991) 1.95
The roles of pain catastrophizing and anxiety in the prediction of postoperative pain intensity: a prospective study. Clin J Pain (2005) 1.73
The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry (2006) 1.67
Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry (1998) 1.62
A double dissociation in the affective modulation of startle in humans: effects of unilateral temporal lobectomy. J Cogn Neurosci (2001) 1.45
Startle reflex modification: emotion or attention? Psychophysiology (1990) 1.34
Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl) (2002) 1.22
When good things go bad: the reflex physiology of defense. Psychol Sci (2005) 1.20
Startle modulation during conscious emotion regulation is arousal-dependent. Behav Neurosci (2005) 1.15
Fear-potentiated startle and posttraumatic stress symptoms in urban police officers. J Trauma Stress (2003) 1.09
Effects of threat of shock, shock electrode placement and darkness on startle. Int J Psychophysiol (1998) 1.07
Tobacco withdrawal and negative affect: an analysis of initial emotional response intensity and voluntary emotion regulation. J Abnorm Psychol (2006) 1.06
Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J Psychopharmacol (1999) 0.99
Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study. Psychopharmacology (Berl) (2001) 0.98
Startle potentiation: shock sensitization, aversive learning, and affective picture modulation. Behav Neurosci (1998) 0.96
Fear-relevant selective associations and covariation bias. J Abnorm Psychol (1989) 0.95
Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man. J Psychopharmacol (2005) 0.89
Effects of lorazepam on fear-potentiated startle responses in man. J Psychopharmacol (2005) 0.87
Covariation bias for phylogenetic versus ontogenetic fear-relevant stimuli. Behav Res Ther (1997) 0.81
Illusory correlation and social anxiety. Behav Res Ther (1998) 0.80
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry (2006) 11.84
Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology (2010) 5.07
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry (2010) 4.85
Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther (2005) 3.83
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry (2010) 2.98
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry (2012) 2.74
Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry (2005) 2.62
Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am J Psychiatry (2009) 2.33
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology (2012) 2.17
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry (2006) 2.09
Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry (2008) 2.05
Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychol Med (2005) 1.99
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry (2004) 1.92
Generalization of conditioned fear-potentiated startle in humans: experimental validation and clinical relevance. Behav Res Ther (2008) 1.84
A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry (2006) 1.83
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biol Psychiatry (2012) 1.76
Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nat Protoc (2012) 1.75
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord (2007) 1.74
Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav Res Ther (2008) 1.73
Contextual fear conditioning in humans: cortical-hippocampal and amygdala contributions. J Neurosci (2008) 1.72
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry (2003) 1.72
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry (2008) 1.71
Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry (2003) 1.68
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry (2005) 1.65
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology (2010) 1.65
Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci (2004) 1.61
Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry (2008) 1.57
Phasic and sustained fear in humans elicits distinct patterns of brain activity. Neuroimage (2010) 1.55
Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry (2005) 1.55
The adaptive threat bias in anxiety: amygdala-dorsomedial prefrontal cortex coupling and aversive amplification. Neuroimage (2011) 1.52
Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry (2005) 1.51
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry (2010) 1.51
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Mov Disord (2011) 1.47
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry (2012) 1.47
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord (2007) 1.46
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry (2005) 1.44
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry (2003) 1.44
Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry (2008) 1.42
Cerebral blood flow in immediate and sustained anxiety. J Neurosci (2007) 1.38
Contextual-specificity of short-delay extinction in humans: renewal of fear-potentiated startle in a virtual environment. Learn Mem (2007) 1.36
Neural responses to auditory stimulus deviance under threat of electric shock revealed by spatially-filtered magnetoencephalography. Neuroimage (2007) 1.36
A single administration of testosterone reduces fear-potentiated startle in humans. Biol Psychiatry (2006) 1.34
The strong situation: a potential impediment to studying the psychobiology and pharmacology of anxiety disorders. Biol Psychol (2005) 1.33
Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J Am Acad Child Adolesc Psychiatry (2009) 1.32
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression. Biol Psychiatry (2013) 1.31
Electroencephalographic measures of regional hemispheric activity in offspring at risk for depressive disorders. Biol Psychiatry (2005) 1.31
Development of anxiety: the role of threat appraisal and fear learning. Depress Anxiety (2010) 1.31
The effect of induced anxiety on cognition: threat of shock enhances aversive processing in healthy individuals. Cogn Affect Behav Neurosci (2011) 1.30
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry (2004) 1.29
Human hippocampal and parahippocampal theta during goal-directed spatial navigation predicts performance on a virtual Morris water maze. J Neurosci (2008) 1.29
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics (2006) 1.29
The impact of anxiety upon cognition: perspectives from human threat of shock studies. Front Hum Neurosci (2013) 1.25
Fear conditioning in adolescents with anxiety disorders: results from a novel experimental paradigm. J Am Acad Child Adolesc Psychiatry (2008) 1.25
Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder. Am J Psychiatry (2007) 1.23
Evidence for continuing neuropsychological impairments in depression. J Affect Disord (2004) 1.23
Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl) (2002) 1.22
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu Rev Pharmacol Toxicol (2014) 1.21
Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry (2008) 1.21
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biol Psychiatry (2013) 1.21
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol (2012) 1.20
Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry (2002) 1.18
Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology (2007) 1.17
Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage (2010) 1.16
Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. Neuroimage (2009) 1.16
Automated subcortical segmentation using FIRST: test-retest reliability, interscanner reliability, and comparison to manual segmentation. Hum Brain Mapp (2012) 1.14
Different neural pathways to negative affect in youth with pediatric bipolar disorder and severe mood dysregulation. J Psychiatr Res (2011) 1.14
Describing the interplay between anxiety and cognition: from impaired performance under low cognitive load to reduced anxiety under high load. Psychophysiology (2012) 1.13
Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry (2004) 1.13
Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry (2006) 1.13
Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry (2006) 1.13
Distinct neural signatures of threat learning in adolescents and adults. Proc Natl Acad Sci U S A (2011) 1.12
Evoked amygdala responses to negative faces revealed by adaptive MEG beamformers. Brain Res (2008) 1.12
Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine. Biol Psychiatry (2012) 1.12
Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenet Genomics (2005) 1.10
Acute exposure to stress improves performance in trace eyeblink conditioning and spatial learning tasks in healthy men. Learn Mem (2007) 1.10
Probing for hemispheric specialization for motor skill learning: a transcranial direct current stimulation study. J Neurophysiol (2011) 1.09
Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children. J Affect Disord (2003) 1.09
Response to learned threat: An FMRI study in adolescent and adult anxiety. Am J Psychiatry (2013) 1.09
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.09
Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression. Biol Psychiatry (2012) 1.09
5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry (2007) 1.09
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol Psychiatry (2005) 1.09
Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology (2007) 1.08
Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology (2006) 1.08
Reduced posterior hippocampal volume in posttraumatic stress disorder. J Clin Psychiatry (2008) 1.08
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry (2010) 1.06
Fear conditioning in virtual reality contexts: a new tool for the study of anxiety. Biol Psychiatry (2004) 1.06
Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder. Psychiatry Res (2005) 1.05
Stress increases aversive prediction error signal in the ventral striatum. Proc Natl Acad Sci U S A (2013) 1.03
Performance on a virtual reality spatial memory navigation task in depressed patients. Am J Psychiatry (2007) 1.03
Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.03
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry (2008) 1.02